News and Trends 22 Jul 2022
Positive news for Aurinia’s voclosporin drug Lupkynis to treat lupus nephritis
British Columbia-based Aurinia Pharmaceuticals Inc. announced today (July 22) that its voclosporin drug has been recommended for marketing authorization to…